Trial Profile
Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Opicapone (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Bial
- 06 Dec 2014 New trial record